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Mutations in the crumbs homologue 1 (CRB1) gene cause a specific form of retinitis pigmentosa (RP) that is
designated “RP12” and is characterized by a preserved para-arteriolar retinal pigment epithelium (PPRPE) and by
severe loss of vision at age !20 years. Because of the early onset of disease in patients who have RP with PPRPE,
we considered CRB1 to be a good candidate gene for Leber congenital amaurosis (LCA). Mutations were detected
in 7 (13%) of 52 patients with LCA from the Netherlands, Germany, and the United States. In addition, CRB1
mutations were detected in five of nine patients who had RP with Coats-like exudative vasculopathy, a relatively
rare complication of RP that may progress to partial or total retinal detachment. Given that four of five patients
had developed the complication in one eye and that not all siblings with RP have the complication,CRB1mutations
should be considered an important risk factor for the Coats-like reaction, although its development may require
additional genetic or environmental factors. Although no clear-cut genotype-phenotype correlation could be estab-
lished, patients with LCA, which is the most severe retinal dystrophy, carry null alleles more frequently than do
patients with RP. Our findings suggest that CRB1mutations are a frequent cause of LCA and are strongly associated
with the development of Coats-like exudative vasculopathy in patients with RP.
We have described mutations in the CRB1 gene (MIM
604210) in a severe, autosomal recessive form of retinitis
pigmentosa (RP) that is designated “RP12” (MIM
600105) (den Hollander et al. 1999). The gene consists
of 12 exons and exhibits alternative splicing at its 3′ end
(A. I. den Hollander and F. P. M. Cremers, unpublished
data). The CRB1 protein contains 19 epidermal growth
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factor (EGF)-like domains, 3 laminin A globular-like
domains, a transmembrane domain, and a 37-amino
acid cytoplasmic tail; in addition, it is homologous to
the Drosophila crumbs protein. RP12 is a specific form
of RP characterized by a preserved para-arteriolar retinal
pigment epithelium (PPRPE) in the early-to-middle
stages of disease. Patients experience night blindness and
develop a progressive loss of their visual field at !10
years of age. Because of early macular involvement, pa-
tients have severe visual impairment at !20 years of age.
Other features of this type of RP are hyperopia, nystag-
mus, optic-nerve–head drusen, vascular sheathing, and
maculopathy (Heckenlively 1982; van den Born et al.
1994). Mutations have now been identified in 15 pa-
tients who have isolated or autosomal recessive of RP
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Table 1
CRB1 Mutations in Patients Who Have LCA or RP with Coats-like Exudates
DISEASE AND
PATIENT NUMBER INHERITANCE
ALLELE 1 ALLELE 2
Mutation Effect Mutation Effect
LCA:
12831 Isolated 2978GrA Cys948Tyr 2978GrA Cys948Tyr
12859 Recessive 3434TrG Ile1100Arg 4132GrT Glu1333stop
12862 Isolated 2536ArT Lys801stop 2536ArT Lys801stop
12872 Recessive 4127GrT Arg1331His ?
13067 Isolated 3466GrT Glu1111stop 40131GrT Splice defect
16507 Isolated 2978GrA Cys948Tyr 2978GrA Cys948Tyr
16690 Isolated 748-754del Frameshift 2536ArT Lys801stop
RP with Coats-
like exudates:
9439 Recessive 1343CrG, 1433ArG Ser403stop, Tyr433Cys 2425CrT Arg764Cys
16894 Recessive 2816ArG Asn894Ser ?
16937 Recessive 2644GrC, 4195GrA Asp837His, Ala1354Thr 2978GrA Cys948Tyr
16968 Isolated 2978GrA Cys948Tyr 29785GrA Splice defect
17658 Recessive 2536ArT Lys801stop 3676TrC Cys1181Arg
with PPRPE (den Hollander et al. 1999; U. Kellner,
A. I. den Hollander, Y. J. M. de Kok, L. I. van den Born,
F. P. M. Cremers, J. R. Heckenlively, unpublished data).
Leber congenital amaurosis (LCA) is considered the
earliest and most severe form of retinal dystrophy, caus-
ing blindness or severe visual impairment at birth or
during the first months of life. Mutations that lead to
LCA have been detected in GUCY2D (MIM 600179)
(Perrault et al. 1996), RPE65 (MIM 180069) (Gu et al.
1997; Marlhens et al. 1997; Morimura et al. 1998),
CRX (MIM 602225) (Freund et al. 1998; Sohocki et al.
1998; Swaroop et al. 1999), and AIPL1 genes (MIM
604392) (Sohocki et al. 2000a). Mutations in these four
genes account for 15%–30% of LCA cases (Perrault et
al. 1999; Dharmaraj et al. 2000; Lotery et al. 2000;
Sohocki et al. 2001), an indication that more LCA genes
await discovery. Because of the early onset of symptoms
in patients who have RP with PPRPE—and the obser-
vation that mutations in RPE65 and CRX can lead to
both LCA and RP (Gu et al. 1997; Morimura et al. 1998;
Sohocki et al. 1998; Thompson et al. 2000)—we con-
sidered CRB1 to be a good candidate gene for LCA.
Fifty-two unrelated patients with LCA were ascer-
tained by ophthalmologists from six centers in the Neth-
erlands, Germany, and the United States. The diagnosis
of LCA is made when patients are nonseeing or visually
inattentive in infancy and have a nonrecordable electro-
retinogram when investigated at !1 year of age (Foxman
et al. 1985). In early stages, the fundus is, typically,
blond; however, in three patients (13067, 16507, and
16690), there was a preservation of the retinal pigment
epithelium (RPE) that is characteristic for RP with
PPRPE. We used 25 primer sets to screen exons 1–11
of the CRB1 gene by single-strand conformation anal-
ysis, as described elsewhere (den Hollander et al. 1999),
but we replaced the primer set for exon 5 by primers
5′-TAATTCAACACCTTTGACTTAGC-3′ and 5′-TGC-
CATAAAATACCAGAAAGTC-3′. Primers used to
amplify exon 12 were 5′-CCTGAGTAGTTCCATTG-
TCC-3′ and 5′-ATTCACAGTGTGTGGATCCC-3′.
Products that migrated differently through the gel were
analyzed by sequencing. When only one allele was iden-
tified in a patient, the patient’s sample was also subjected
to sequence analysis of all 26 amplicons and of the pro-
moter region of CRB1, which contains several putative
photoreceptor-gene regulatory sites (A. I. den Hollander
and F. P. M. Cremers, unpublished data), with primers
5′-GTAAAAATCAGCTATAGAAATTGC-3′ and 5′-
TTTTCTGTTCATAAATTATATTCCC-3′ (800 to
345), and primers 5′-TAAGTTTTCTTCTGTCTTG-
GCC-3′ and 5′-CTGAGGTAGAAGATGAGAAGG-3′
(421 to 179).
In eight patients with LCA, nine distinct sequence
changes in the coding region or splice sites of CRB1
were found (table 1; homozygous Thr821Met poly-
morphism in proband 12864 not depicted—see below).
Two of the changes (Lys801stop and Cys948Tyr) had
been identified by us previously (den Hollander et al.
1999; U. Kellner, A. I. den Hollander, Y. J. M. de Kok,
L. I. van den Born, F. P. M. Cremers, J. R. Heckenlively,
unpublished data) in patients who had RP with PPRPE,
but seven of them (748-754del, Thr821Met, Ile1100Arg,
Glu1111stop, 40131GrT, Arg1331His, and
Glu1333stop) had not been identified previously and
were not found in 180 control chromosomes. For two
probands (12859 and 12864), DNA samples of family
members were available for cosegregation analysis (for
patient 12859, see fig. 1A). Proband 12864 and one of
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Figure 1 Cosegregation analysis of CRB1 mutations in (A) one
family with LCA and (B) five families with RP and Coats-like exudates.
A question mark (?) denotes the unidentified second allele; an asterisk
(*) denotes patients with RP who have developed the Coats-like com-
plication. Arrows indicate probands. IVS8 denotes the splice-site mu-
tation of exon 8, 29785GrA.
her unaffected sisters were homozygous for Thr821Met,
which suggested that this sequence change is not path-
ogenic. In patient 12872, only one allele was identified.
No sequence changes were detected in the 800 bp that
precede the transcription-start site, which suggested that
the second allele may be present in other, unidentified
regulatory elements or splice variants of the gene or may
involve a large deletion that was not detected by PCR
analysis.
Of 13 alleles identified in patients with LCA, 7 were
nonsense, frameshift, or splice-site mutations, which is
a larger proportion than is found on CRB1 alleles of
patients who have RP with PPRPE (4 of 30 alleles; den
Hollander et al. 1999; U. Kellner, A. I. den Hollander,
Y. J. M. de Kok, L. I. van den Born, F. P. M. Cremers,
J. R. Heckenlively, unpublished data). In three patients
we identified null mutations on bothCRB1 alleles, which
suggests that LCA is the most severe phenotype that
can be associated with mutations in CRB1. Two pa-
tients with LCA were homozygous for the mutation
(Cys948Tyr) that is most frequently found in patients
who have RP with PPRPE. In four patients who had RP
with PPRPE, this mutation was found in combination
with another missense mutation; and in one patient who
had RP with PPRPE, it was found together with a splice-
site mutation (29785GrA) that does not necessarily
render the mutant splice site completely inactive (den
Hollander et al. 1999). These findings suggest that
Cys948Tyr is a severe mutation that leads to a severe
phenotype when it is present homozygously. Cys948Tyr
changes the 4th conserved cysteine residue of the 14th
EGF-like domain of CRB1, which is involved in the for-
mation of disulfide bridges and thus in the correct fold-
ing of the EGF-like domain.
Pathogenic CRB1 mutations were identified in 7
(13%) of 52 unrelated patients with LCA from the Neth-
erlands, Germany, and the United States. Mutations in
GUCY2D, RPE65, AIPL1, and CRX account for
6%–20%, 3%–16%, 7%, and 2%–3% of LCA cases,
respectively (Morimura et al. 1998; Dharmaraj et al.
2000; Lotery et al. 2000; Perrault et al. 2000; Sohocki
et al. 2000b; Thompson et al. 2000), which suggests
that CRB1 mutations contribute significantly to the eti-
ology of LCA.
To determine whether mutations in the CRB1 gene
are a common cause of RP in the Dutch population, we
screened 97 unrelated patients who had isolated or au-
tosomal recessive RP for the presence of Cys948Tyr and
Arg764Cys. These mutations had been previously iden-
tified in 5 and 3 CRB1 alleles, respectively, of a total of
30 CRB1 alleles of unrelated patients who had RP
with PPRPE (den Hollander et al. 1999; U. Kellner,
A. I. den Hollander, Y. J. M. de Kok, L. I. van den Born,
F. P. M. Cremers, J. R. Heckenlively, unpublished data).
The presence of the nucleotide alteration 2425CrT
(Arg764Cys) was analyzed by allele-specific oligonu-
cleotide (ASO) hybridization (Shuber et al. 1993), using
wild-type primer 5′-AATATATCCGTGTCTGG-3′ and
mutant primer 5′-AATATATCTGTGTCTGG-3′. The
presence of 2978GrA (Cys948Tyr), was analyzed with
the amplification-refractory mutation system (Newton
et al. 1989) with sense primers 5′-ATTATCACCTTCT-
CTCATTAGG-3′ (wild-type allele) or 5′-ATTATCACC-
TTCTCTCATTAGA-3′ (mutant allele) and antisense
primer 5′-GTGCCATCATTCACTGACTG-3′. One of
the 97 patients (patient 9439) carried the Arg764Cys
mutation on one allele. Sequencing of the 12 exons of
CRB1 revealed two more sequence changes (Ser403stop
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Figure 2 Fundus photograph of the inferior part of the left eye of a patient who had RP with unilateral Coats-like exudative vasculopathy
(proband 9439; individual II-4). Note the widespread subretinal yellowish-white deposits between the neural retina and RPE in the lower part.
This region of the fundus is out of focus as a result of the elevation of tissue caused by subretinal accumulation of fluid. Triangles () indicate
retinal vessels with white sheathing that is indicative of vasculitis. The RPE shows some preservation near retinal arterioles as seen in patients
who had RP with PPRPE (arrow).
and Tyr433Cys), both of which are located on the sec-
ond allele, as determined by allele-specific PCR (data
not shown) and segregation analysis (fig. 1).
As a complication of RP, proband 9439 (individual
II-4) (fig. 2) and his affected brother (II-5) had developed
a Coats-like exudative vasculopathy, which caused ad-
ditional loss of vision. Coats-like exudative vasculopa-
thy, a relatively rare complication of RP, can develop in
later stages of the disease and is characterized by vas-
cular abnormalities (aneurysmal dilations and telangi-
ectatic retinal veins), yellow extravascular lipid deposi-
tions, and retinal detachment. Patients with RP who
develop Coats-like changes show a wide spectrum of
disorders, ranging from mild visual difficulties or nyc-
talopia, as observed in classical RP, to the other extreme,
in which a proliferative vasculopathy develops. If un-
treated, this proliferative vasculopathy may result in a
painful blind eye caused by rubeosis, retinal neovascu-
larization, or serous retinal detachment. It has been sug-
gested that genetic factors may be involved in RP with
Coats-like exudative vasculopathy (Khan et al. 1988).
We therefore hypothesized that CRB1 mutations may
be associated with the development of this complication
of RP, and we ascertained eight additional isolated or
autosomal recessive patients who had RP with Coats-
like exudative vasculopathy. These patients were tested
for mutations in CRB1 by sequence analysis of all 26
amplicons. Five of the eight patients had sequence
changes, and clinical descriptions of these patients are
summarized in table 2.
In one patient, we identified three sequence changes;
in two patients, we found compound heterozygous mu-
tations; and in one patient, we identified one allele (table
1). Screening of the promoter region of CRB1 in the
patient with one allele revealed no sequence changes.
Cosegregation analysis in family members of all five
probands confirmed autosomal recessive inheritance of
CRB1 mutations (fig. 1). Of the 10 different sequence
changes identified in the five patients who had RP with
Coats-like exudates, five mutations (Ser403stop,
Arg764Cys, Lys801stop, Cys948Tyr, and 29785GrA)
have been identified previously in patients who had RP
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Table 2
Clinical Features of Patients with RP and Coats-like Exudates
Patient and Age
at Onset of RP
Coats Reaction
and Age at Onseta PPRPE Refractionb
9439, !10 years U, 20 years Yes 5.25
16894, 28 years U, 30 years No 6.00
16937, 110 years U, 27 years No 4.50
16968, !10 years U, 20 years ? ?
17658, !10 years B, 20 years No 1.00
NOTE.—? p unknown.
a B p bilateral; U p unilateral.
b Spherical equivalent.
with PPRPE. The other five changes (Tyr433Cys,
Asp837His, Asn894Ser, Cys1181Arg, and Ala1354Thr)
had not previously been identified in patients who had
RP with PPRPE or in patients with LCA, and the changes
were not found in 180 control chromosomes.
Coats-like exudative vasculopathy occurs in only
1.2%–3.6% of patients with RP (Khan et al. 1988).
Among patients who had both RP and PPRPE and were
described by Van den Born et al. (1994), 2 (8.3%) of
24 had Coats-like changes, and CRB1 mutations were
found in these patients (den Hollander et al. 1999). At
least one patient described in the present study (patient
II-4 in family 9439) had RP with Coats-like changes and
PPRPE. However, the disorders of two patients (patient
II-2 in family 16894 and patient II-2 in family 16937)
were clearly distinct from RP with PPRPE. In both pa-
tients, the onset of RP occurred when patients were 110
years old. Neither patient showed a preservation of the
RPE surrounding the arterioles, and one patient was
highly myopic.
Our findings show that CRB1 mutations are associ-
ated with Coats-like exudative vasculopathy in patients
who have RP with or without the PPRPE phenotype.
These findings demonstrate that patients with PPRPE
should be checked regularly for the Coats-like compli-
cation. Furthermore, the routine screening of patients
with autosomal recessive or isolated RP may be impor-
tant because of its ability to reveal those patients who
are at increased risk of developing exudative retinal de-
tachment. If the process is detected before it becomes
proliferative, cryotherapy can be used to prevent further
progression.
Not all affected siblings of patients who have RP with
Coats-like exudative vasculopathy develop the Coats-
like complication (e.g., families 16894 and 17658 [fig.
1]). This finding, together with the observation that most
patients with CRB1 mutations had developed unilateral
Coats-like exudates, strengthens the idea thatCRB1mu-
tations are an important risk factor for the development
of the Coats-like reaction and that other genetic or en-
vironmental factors may be involved. Interestingly, no
CRB1 mutations were identified in 13 (45%) of 29 pa-
tients who had RP with PPRPE (U. Kellner, A. I. den
Hollander, Y. J. M. de Kok, L. I. van den Born, F. P. M.
Cremers, J. R. Heckenlively, unpublished data), and in
the present study we did not detect CRB1 mutations in
four of nine patients who had RP with Coats-like ex-
udates, which suggests that another gene may be in-
volved in these two specific forms of RP.
We found no obvious genotype-phenotype correlation
when we compared mutations in patients who had both
RP and PPRPE with those in patients who had LCA or
RP with Coats-like exudates. However, the absence of
clear-cut null mutations on both CRB1 alleles of 15 pa-
tients who had RP with PPRPE and of 5 patients who
had RP with Coats-like exudates, together with the pres-
ence of null mutations on both CRB1 alleles in 3 patients
with LCA, suggests that LCA may be associated with
complete loss of function of CRB1. In contrast, patients
who have RP with PPRPE and patients who have RP
with Coats-like exudates may have residual CRB1
function.
RP with PPRPE, RP with Coats-like exudative vas-
culopathy, and LCA represent different (but partly over-
lapping) clinical entities, as evidenced by the presence of
the PPRPE characteristics in some patients with LCA
and the higher-than-average incidence of Coats-like
changes in patients who had RP with PPRPE. Because
our genotype-phenotype comparison did not reveal con-
clusive evidence of qualitative or quantitative differences
in CRB1 function in these patient groups, functional
studies of CRB1 are necessary to shed light on this in-
triguing issue. We suggest that other genetic—and pos-
sibly environmental—factors influence the expression of
CRB1 mutations, thereby contributing to the wide spec-
trum of features that have been described in the present
study.
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